๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Concluding remarks

โœ Scribed by V. Hird; A. A. Epenetos


Publisher
John Wiley and Sons
Year
1988
Tongue
French
Weight
92 KB
Volume
41
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Concluding remarks
โœ Pierre Karli ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 2 views
Concluding remarks
โœ J. V. Maloney ๐Ÿ“‚ Article ๐Ÿ“… 1970 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 1 views
Concluding remarks
โœ George Higginbottom ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons โš– 446 KB ๐Ÿ‘ 1 views
Concluding remarks
โœ Stella Somiari ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 436 KB
Concluding remarks
โœ K. Sikora ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 47 KB

This meeting has enabled those actively involved in the clinical investigation of IFN alfa-2a to present the most recent data available on 5 different types of tumour. There is now no doubt that recombinant IFN has an effect on the growth of several malignant disorders. In Kaposi's sarcoma and hairy

Concluding remarks
โœ A. A. Epenetos ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 68 KB

This meeting provided an opportunity for both experts and newcomers to present and discuss their achievements as well as their difficulties in fundamental and applied areas of monoclonal antibodies in oncology. Detailed immunochemical studies are helping us to select new antibodies with more favoura